599TiP A prospective study of savolitinib plus docetaxel in pretreated EGFR/ALK/ROS1/METex14m-wildtype advanced NSCLC patients with MET overexpression (FirstMET).

Subjects

Subjects :

*DOCETAXEL
*EPIDERMAL growth factor receptors
*LONGITUDINAL method
*GENETIC overexpression
*NON-small-cell lung carcinoma

Details

Language :

English

ISSN :

09237534

Volume :

34

Database :

Academic Search Index

Journal :

Annals of Oncology

Publication Type :

Academic Journal

Accession number :

173758555

Full Text :

https://doi.org/10.1016/j.annonc.2023.10.677